Clinical trial
High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With…
NCT00003032 · NCIC Clinical Trials Group, Other · Completed
Key facts
| NCT number | NCT00003032 |
|---|---|
| Title | High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer |
| Official title | A Randomized Trial of High-Dose Chemotherapy and Autologous Stem Cell Therapy Versus Standard Therapy in Women With Metastatic Breast Cancer Who Have Responded to Anthracycline or Taxane-Based Induction Chemotherapy |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Biological, Drug |
| Interventions | filgrastim, cisplatin, cyclophosphamide, mitoxantrone hydrochloride, tamoxifen citrate |
| Enrollment | 224 |
| Start date | Apr 25, 1997 |
| Primary completion | Apr 12, 2001 |
| Completion | Dec 15, 2008 |
| First posted | Apr 14, 2004 |
| Last update posted | Apr 1, 2020 |
| Countries | Canada |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: